Nadim, Mitra K.
Forni, Lui G. http://orcid.org/0000-0002-0617-5309
Mehta, Ravindra L.
Connor, Michael J. Jr http://orcid.org/0000-0001-7613-5583
Liu, Kathleen D. http://orcid.org/0000-0003-4891-8649
Ostermann, Marlies
Rimmelé, Thomas
Zarbock, Alexander
Bell, Samira http://orcid.org/0000-0001-9100-1575
Bihorac, Azra http://orcid.org/0000-0002-5745-2863
Cantaluppi, Vincenzo
Hoste, Eric http://orcid.org/0000-0001-9301-8055
Husain-Syed, Faeq
Germain, Michael J. http://orcid.org/0000-0001-7481-2421
Goldstein, Stuart L.
Gupta, Shruti http://orcid.org/0000-0002-5747-2151
Joannidis, Michael http://orcid.org/0000-0002-6996-0881
Kashani, Kianoush http://orcid.org/0000-0003-2184-3683
Koyner, Jay L.
Legrand, Matthieu http://orcid.org/0000-0001-9788-5316
Lumlertgul, Nuttha http://orcid.org/0000-0003-1506-4253
Mohan, Sumit
Pannu, Neesh
Peng, Zhiyong
Perez-Fernandez, Xose L. http://orcid.org/0000-0002-5903-6927
Pickkers, Peter
Prowle, John http://orcid.org/0000-0002-5002-2721
Reis, Thiago http://orcid.org/0000-0002-7071-117X
Srisawat, Nattachai
Tolwani, Ashita
Vijayan, Anitha
Villa, Gianluca
Yang, Li
Ronco, Claudio http://orcid.org/0000-0002-6697-4065
Kellum, John A. http://orcid.org/0000-0003-1995-2653
Article History
Accepted: 9 September 2020
First Online: 15 October 2020
Change Date: 2 November 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: L.G.F. has received grant and/or research support from Baxter and speaker’s honoraria from bioMérieux and Ortho Clinical diagnostics. R.L.M. has received grant and/or research support from Fresenius and Fresenius-Kabi and consulting fees from AM-Pharma, Sphingotec, Akebia, GE healthcare, Indalo, bioMérieux, Intercept, Baxter, Medtronic and Mallinckrodt. M.J.C. has received grant and/or research support from NIH and Potrero Medical Inc. K.D.L. has received consulting fees from bioMérieux and Durect. M.O. has received grant and/or research support from Baxter. T. Rimmelé has received grant and/or research support from Baxter and consulting fees from Baxter, Fresenius Medical Care, bioMérieux, Braun and Nikkiso. A.Z. has received grant and/or research support from Astute Medical, Fresenius, Baxter, Astellas, DFG, EK and consulting fees from Baxter, Astute Medical, bioMérieux, La Jolla Pharmaceuticals, Fresenius, Braun, AM-Pharma, Astellas and Radiopharma. S.L.G. has grant and/or research support and consulting fees from ExThera, BioPorto, Baxter and SeaStar, speaker’s honoraria from Baxter and Fresenius and is a stockholder for MediBeacon. S.G. has received consulting fees from GlaxoSmithKline. M.J. has received grant and/or research support from Baxter. J.L.K. has received grant and/or research support from NxStage, Satellite Health Care, and consulting fees from Astute Medical, Baxter, Sphingotec, and honoraria from the American Society of Nephrology. M.L. has received grant and/or research support from Sphingotec and consulting fees from Novartis. S.M. has received consulting fees from Angion Biomedica. X.L.P.-F. has received speaker’s honoraria from Baxter. P.P. has received travel and consulting fees from AM-Pharma, EBI and Sphingotec. J.P. has received grant and/or research support from bioMérieux, consulting fees from Quark Pharmaceutical and Medibeacon Inc., and speaker’s honoraria from Nikkiso Europe GmbH, Baxter, Braun Medical Ltd, Fresenius Medical Care and Fresenius-Kabi UK. T. Reis. has received consulting fees from Baxter and Eurofarma and speaker’s honoraria from Baxter and Braun. N.S. has received grant and/or research support from Baxter. A.T. has received consulting fees and speaker’s honoraria from Baxter and has a patent on 0.5% citrate solution for continuous renal replacement therapy. A.V. has received consulting fees for NxStage and has received other fees from Boehringer Ingelheim. G.V. has received grant and/or research support from Baxter SpA. C.R. has received consulting fees from Baxter, Jfron, bioMérieux, Medtronic and speaker’s honoraria from GE, OCD, and Cytosorbents. J.A.K. has received grant and/or research support from Astellas, Astute Medical, Baxter, bioMérieux, Cytosorbents, RenalSense, consulting fees from Astellas, Astute Medical, Baxter, bioMérieux, Cytosorbents, RenalSense, DaVita, Fresenius, Mallinckrodt, NxStage, Potrero, and has licensing of intellectual property for Astute Medical and Cytosorbents. The other authors declare no competing interests.